Skip to Content

What is Tagrisso used for?

Answers (1)

Official Answer by 9 Mar 2016

Tagrisso (generic name: osimertinib), manufactured by AstraZeneca Pharmaceuticals, is a EGFR tyrosine kinase inhibitor used for the treatment of advanced non-small cell lung cancer (NSCLC).

Tagrisso is approved for the population of patients with metastatic EGFR T790M mutation-positive NSCLC who have progressed while receiving or after EGFR TKI therapy. The FDA also approved the companion diagnostic cobas EGFR Mutation Test v2 to detect EGFR mutations in patients with non-small cell lung cancer, including T790M.

Tagrisso tablets are taken orally once daily, with or without food.

The most common side effects of Tagrisso include diarrhea, and skin and nail conditions such as dry skin, rash and infection or redness around the fingernails.

Votes: +0 free discount card

Further Information

Search for questions

Still looking for answers? Try searching for what you seek or ask your own question.

Frequently Asked Questions

How does Yosprala work?

Posted 30 Nov 2016 1 answerFAQ by

How is Cuvitru administered?

Posted 30 Nov 2016 1 answerFAQ by

What is the difference between Erelzi and Enbrel?

Posted 30 Nov 2016 1 answerFAQ by

How is Troxyca ER formulated to be abuse deterrent?

Posted 30 Nov 2016 1 answerFAQ by

How long does the flu last for?

Posted 16 Dec 2016 1 answerFAQ by